First Commonwealth Financial
FCF
19.86
-0.20
-1.00%
First Commonwealth Financial
US · FCF
#2754 by market cap
Listed 1970
19.86
-0.20
-1.00%
Live - 5344 symbols - heartbeat 449s ago
· 2026-10-08 05:48
Pre-market
19.83
-0.13%
After-hours
19.86
0.00%
- Market cap
- 2.01B
- P/E (TTM)i
- 12.11
- P/Bi
- 1.28
- EPSi
- 1.47
- Div yieldi
- 2.74%
- 52W posi
- 69%
Reader sentiment
Are you bullish or bearish on FCF?
Anonymous reader poll. Unscientific, not investment advice.
Recent news
-
Rating change
Piper Sandler Maintains First Commonwealth Financial(FCF.US) With Buy Rating, Raises Target Price to $25Market Newswire · 2026/7/30
-
Rating change
Piper Sandler Maintains First Commonwealth Financial(FCF.US) With Buy Rating, Maintains Target Price $21Market Newswire · 2026/4/30
-
Company notice
Kinnate BioPharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Foresite Capital Fund IV, L.P. (“FCF IV”)(0%),Foresite Capital Management IV, LLC (“FCM IV”)(0%), etc.SEC · 2024/4/6
-
D.A. Davidson Initiates First Commonwealth Financial(FCF.US) With Hold Rating, Announces Target Price $24Market Newswire · 2026/9/29
-
Company notice
Trimtabs All Cap U.S. Free-Cash-Flow Etf: FCF US Quality ETF - Name/Symbol Change Option Symbol: TTAC New Symbol: ABFLOCC · 2024/12/12
-
KBW Maintains First Commonwealth Financial(FCF.US) With Hold Rating, Raises Target Price to $24Market Newswire · 2026/7/31
-
Rating change
Analyst Reaffirms Buy on James Hardie as Structural Growth, Robust FCF Outlook Offset Price Target Cut to A$38.20TipRanks · 2026/5/21
-
Rating change
KBW Maintains First Commonwealth Financial(FCF.US) With Hold Rating, Raises Target Price to $20Market Newswire · 2026/1/29
-
Company notice
Lyell Immunopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-James Tananbaum (“Tananbaum”)(5.3%),Foresite Capital Fund IV, L.P. (“FCF IV”)(3.2%), etc.SEC · 2024/11/1
-
Rating change
Research Alert: Tou Q1: Record Q1 Production, Raises 2026-2027 Fcf Outlook To Cad0.9b AnnuallyMT Newswires · 2026/5/7
-
Company notice
CASI Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Foresite Capital Fund VI, L.P. (“FCF VI”)(9.8%),Foresite Capital Management VI, LLC (“FCM VI”)(9.8%), etc.SEC · 2024/6/21
-
Company notice
SC 13G: Statement of acquisition of beneficial ownership by individuals-Foresite Capital Fund VI, L.P. (“FCF VI”)(5.8%),Foresite Capital Management VI, LLC (“FCM VI”)(5.8%), etc.SEC · 2024/2/23
-
Raymond James Maintains First Commonwealth Financial(FCF.US) With Buy Rating, Raises Target Price to $24Market Newswire · 2026/7/31
-
Rating change
RBC Capital Maintains First Commonwealth Financial(FCF.US) With Buy Rating, Maintains Target Price $19Market Newswire · 2026/1/29
-
Commerce.com: Cost Restructuring, Strong FCF Outlook, and Share Repurchase Support Unchanged $7.5 Price Target and Buy RatingTipRanks · 2026/9/11
-
Rating change
BCE Inc.: Attractive AI-Driven Growth Offset by Near-Term FCF Pressure and Limited Upside, Justifying Hold RatingTipRanks · 2026/3/17
-
D.A. Davidson Maintains First Commonwealth Financial(FCF.US) With Hold Rating, Maintains Target Price $24Market Newswire · 2026/10/1
-
Rating change
Research Alert: Tfii Q4: U.s. Ltl Or Down And Fcf Up 25%, Yet Q1 Eps Guidance Was WeakMT Newswires · 2026/2/18
-
Rating change
KBW Maintains First Commonwealth Financial(FCF.US) With Hold Rating, Raises Target Price to $21Market Newswire · 2026/4/30
-
Rating change
Raymond James Upgrades First Commonwealth Financial(FCF.US) to Buy Rating, Announces Target Price $20Market Newswire · 2026/1/7
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-10-08 05:48:55 · For reference only, not investment advice and not tailored to your situation.